Bastiaan Jeroen van der Baan, Director at LIXTE BIOTECHNOLOGY HOLDINGS, INC. (LIXT), bought 10,000 shares at $0.49 ($5K) on 2022-12-30, disclosed to the SEC on 2023-01-05.
Open-market purchase of $5k LIXT by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Something here stands out, but not much.
| Filing → |